The FDA mentioned J&J’s vaccine presents robust safety towards what issues most: critical sickness, hospitalizations and loss of life. One dose was 85% protecting towards probably the most extreme COVID-19 sickness, in a large examine that spanned three continents – safety that remained robust even in nations comparable to South Africa, the place the variants of most concern are spreading.
“The more vaccines that have high efficacy that we can get into play, the better,” Dr. Anthony Fauci, the highest US infectious illness professional, mentioned forward of the FDA’s ruling.
Shipments of some million doses to be divided amongst states may start as early as Monday. By the tip of March, J&J has mentioned it expects to ship 20 million doses to the US, and 100 million by summer season.
J&J is also in search of authorization for emergency use of its vaccine in Europe and from the World Health Organization. Worldwide, the corporate goals to supply about 1 billion doses globally by the tip of the yr. On Thursday, the island nation of Bahrain grew to become the primary to clear its use.